CD4 and arthritic joint disease: have shown that a combined inhibition of glutamine metabolism and mTOR significantly suppressed CD4+ T cell activation-mediated arthritis in mice better than each monotherapy, implying the essential role of cellular metabolism in immune cell mTOR signaling (25).